MedPath

Pennsaid

These highlights do not include all the information needed to use PENNSAID safely and effectively. See full prescribing information for PENNSAID. PENNSAID (diclofenac sodium) topical solution 2% w/w, for topical use Initial U.S. Approval: 1988

Approved
Approval ID

802cd382-443d-48e3-9c9d-fd946c73c79f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 8, 2022

Manufacturers
FDA

Horizon Therapeutics USA, Inc.

DUNS: 033470838

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

diclofenac sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code75987-040
Application NumberNDA204623
Product Classification
M
Marketing Category
C73594
G
Generic Name
diclofenac sodium
Product Specifications
Route of AdministrationTOPICAL
Effective DateFebruary 8, 2022
FDA Product Classification

INGREDIENTS (6)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
DIMETHYL SULFOXIDEInactive
Code: YOW8V9698H
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
DICLOFENAC SODIUMActive
Quantity: 20 mg in 1 g
Code: QTG126297Q
Classification: ACTIB
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pennsaid - FDA Drug Approval Details